RenovaCare Announces Termination of StemCell Systems R&D Agreement
03. Mai 2022 10:06 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare Announces Management Changes
24. März 2022 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare Provides Clinical and Corporate Update
09. März 2022 15:35 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for...
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent
14. Oktober 2021 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...
RenovaCare Provides Update on Clinical Trial for the SkinGun™ and CellMist™ System for Wound Healing
22. Juli 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for the regeneration of skin and other organs and...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
07. Juni 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
RenovaCare Responds to SEC Complaint
01. Juni 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced that it intends to vigorously defend itself and its stockholders against...
FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial
06. Mai 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that its Investigational Device Exemption (IDE) application has been granted...
RenovaCare Announces Organizational Changes and Appointment of New Officers
30. März 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
25. Februar 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...